Ebola vaccine: Promising phase I trials

The clinical phase I trial of a potential vaccine against the dreaded Ebola virus has been successfully completed at four partner sites in Africa and Europe. The safety of the tested vaccine ‘rVSV-ZEBOV’, which induces persistent antibodies against the virus, has been confirmed by researchers.